2026-09-29T12:50:18.000Z · 13 days ago Vivos Therapeutics reports progress in material cost reductions, revenue growth
Sep 29, 2026, 8:45 AM EDT · 13 days ago Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
Sep 1, 2026, 8:00 AM EDT · 5 weeks ago Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference
2026-08-28T12:50:10.000Z · 6 weeks ago Vivos Therapeutics, SPCVA to launch regional sleep testing and treatment center
Aug 28, 2026, 8:45 AM EDT · 6 weeks ago Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
2026-08-25T12:56:23.000Z · 6 weeks ago Vivos Therapeutics reports new patient referrals at Nevada Sleep & Airway
Aug 25, 2026, 8:45 AM EDT · 6 weeks ago Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
2026-08-20T14:30:19.000Z · 7 weeks ago Vivos Therapeutics opens sleep testing, treatment facility in Nevada
Aug 20, 2026, 10:24 AM EDT · 7 weeks ago Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment
Aug 14, 2026, 4:28 PM EDT · 1 month ago Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
Aug 14, 2026, 8:45 AM EDT · 1 month ago Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
2026-08-11T13:11:51.000Z · 2 months ago Vivos Therapeutics expands strategic engagement with Greenway Health
Aug 11, 2026, 8:45 AM EDT · 2 months ago Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
2026-08-05T14:01:57.000Z · 2 months ago Vivos Therapeutics issued new U.S. patent for Vivos CARE devices
Aug 5, 2026, 8:30 AM EDT · 2 months ago Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
2026-07-08T18:10:16.000Z · 3 months ago Vivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global
2026-06-30T13:35:46.000Z · 3 months ago Vivos Therapeutics says Vida oral appliance improves insomnia in study
Jun 30, 2026, 8:45 AM EDT · 3 months ago Vivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
Jun 22, 2026, 8:30 AM EDT · 3 months ago Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
2026-06-11T12:55:08.000Z · 4 months ago Vivos Therapeutics intends to file registration statement for rights offering
Jun 11, 2026, 8:30 AM EDT · 4 months ago Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
2026-06-10T13:18:43.000Z · 4 months ago Vivos Therapeutics enters pact with South Palm Cardiovascular Associates
Jun 10, 2026, 9:03 AM EDT · 4 months ago Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
Jun 8, 2026, 1:39 PM EDT · 4 months ago Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
Jun 5, 2026, 8:45 AM EDT · 4 months ago Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
May 20, 2026, 4:10 PM EDT · 4 months ago Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
May 9, 2026, 11:53 AM EDT · 5 months ago Analysts see 200%+ upside in these 3 high-risk stocks: here's why? ACTU ATAI
2026-04-17T13:52:17.000Z · 5 months ago Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright
2026-04-17T12:43:47.000Z · 5 months ago Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global
Apr 15, 2026, 8:45 AM EDT · 6 months ago Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
Apr 7, 2026, 8:45 AM EDT · 6 months ago Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
Mar 26, 2026, 8:45 AM EDT · 6 months ago Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
2026-03-17T13:00:18.000Z · 6 months ago Vivos Therapeutics’ oral medical devices proven to enhance airways
Mar 17, 2026, 8:45 AM EDT · 6 months ago Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
2026-02-17T11:15:45.000Z · 7 months ago Vivos Therapeutics files to sell 3.96M shares of common stock for holders
2026-02-05T13:50:40.000Z · 8 months ago Vivos, SoundHealth collaborate to expand access to SoundHealth’s technology
2026-02-05T13:50:12.000Z · 8 months ago Vivos Therapeutics signs 12-part media series with New to the Street
Feb 5, 2026, 8:45 AM EST · 8 months ago Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies
Jan 20, 2026, 5:31 PM EST · 8 months ago Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
2026-01-16T13:10:49.000Z · 8 months ago Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds
Jan 16, 2026, 8:00 AM EST · 8 months ago Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
2025-12-16T13:50:29.000Z · 10 months ago Vivos Therapeutics opens sleep center in Auburn Hills, Michigan
Dec 16, 2025, 8:45 AM EST · 10 months ago Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
Nov 19, 2025, 4:20 PM EST · 10 months ago Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
Nov 19, 2025, 8:30 AM EST · 10 months ago Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
Sep 30, 2025, 8:30 AM EDT · 1 year ago Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
Sep 17, 2025, 8:30 AM EDT · 1 year ago Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
Aug 19, 2025, 4:20 PM EDT · 1 year ago Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
Aug 19, 2025, 8:30 AM EDT · 1 year ago Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call
Jun 26, 2025, 8:30 AM EDT · 1 year ago New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children
May 14, 2025, 9:15 AM EDT · 1 year ago Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call
Apr 16, 2025, 8:30 AM EDT · 1 year ago Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
Mar 31, 2025, 4:20 PM EDT · 1 year ago Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
Mar 28, 2025, 8:30 AM EDT · 1 year ago Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
Dec 23, 2024, 8:00 AM EST · 1 year ago Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Nov 13, 2024, 5:00 PM EST · 1 year ago Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
Oct 8, 2024, 7:30 AM EDT · 2 years ago Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
Sep 18, 2024, 7:00 AM EDT · 2 years ago Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
Aug 14, 2024, 4:05 PM EDT · 2 years ago Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
Aug 14, 2024, 7:30 AM EDT · 2 years ago Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call
Jun 27, 2024, 7:30 AM EDT · 2 years ago Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
Jun 12, 2024, 7:30 AM EDT · 2 years ago Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
May 14, 2024, 4:05 PM EDT · 2 years ago Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
May 14, 2024, 7:30 AM EDT · 2 years ago Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
Apr 9, 2024, 7:30 AM EDT · 2 years ago Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Mar 28, 2024, 4:05 PM EDT · 2 years ago Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update